Latest News and Press Releases
Want to stay updated on the latest news?
-
Company announcement no. 26/2026 In accordance with Article 19 (3) of the Market Abuse Regulation, Columbus A/S is required to disclose information regarding trading in Columbus A/S shares and/or...
-
In connection with Borregaard’s Annual General Meeting, Mr. Helge Aasen, Chair of the Board of Directors in Borregaard ASA, has been assigned voting rights based on proxies for 7,906,608 shares in...
-
CALGARY, Alberta, March 26, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company...
-
Rapid7 Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Highlights ISS Agreement: ISS Recommends Stockholders Vote “AGAINST” the ProCap Financial Merger and the Company’s Director Nominee Reminds Stockholders it is Not Too Late to Make Their Voice Heard ...
-
Marex Group plc announces Q1 trading update and hosts Investor Day in New York
-
Í dag, 26. mars 2026, var hlutafé Símans hf. lækkað um 75.000.000 hluti í samræmi við ákvörðun aðalfundar frá 12. mars sl. Lækkunin tekur til eigin hluta sem félagið hefur eignast með kaupum á eigin...
-
BURLINGTON, Mass. and JERUSALEM, March 26, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
-
Contends Driven Brands is Undervalued by the Public Markets due to Structural, Capital Allocation, and Governance Failures Believes That Strategic Process Will Maximize Value for All Shareholders ...
-
CALGARY, Alberta, March 25, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company...